Clinical Trial Update: Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing cobicistat-boosted atazanavir with ritonavir-boosted atazanavir in combination with Emtricitabine/Tenofovir Disoproxil Fumarate in ART…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine) (emtricitabine)
• Norvir (ritonavir) (ritonavir)
• Reyataz (atazanavir) (atazanavir)
• Tybost (cobicistat) (cobicistat)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-10-28